10:23 AM EDT, 08/06/2024 (MT Newswires) -- IDEAYA Biosciences' ( IDYA ) shares were up 1.2% in early Tuesday trading after reporting a Q2 net loss of $0.68 per diluted share.

The company didn't provide year-earlier figures for comparison.

Analysts polled by Capital IQ expected a loss of $0.54.

The precision medicines company also didn't report any revenue for the quarter ended June 30.

Analysts had expected $4.1 million.

IDEAYA had $952.7 million in cash and equivalents on hand at the end of Q2, which the company is expecting will fund its operations into at least 2028.

Price: 37.44, Change: +0.45, Percent Change: +1.22